Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc.

MDยทNYSE

$21.84

+1.0%
HealthcareMedical - Care Facilities

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

At a Glance

Live Snapshot
Market Cap$1.79B
EPS1.9400
P/E Ratio11.26
Earnings Date08/04/2026

Intrinsic Alpha Methodology

Thesis Lenses

Signal ยท Driver ยท Risk

Signal

High confidence

Valuation multiple is compressed (P/E 11.3).

Valuation inputs: P/E 11.3, earnings yield +8.9%, momentum +1.0%.

If multiples stay elevated while momentum fades, downside repricing risk rises.

Driver

High confidence

Return profile is acceptable (ROE +19.1%, ROIC +9.7%).

Profitability stack: net margin +8.6%, ROE +19.1%, ROIC +9.7%.

Quality deterioration often appears in margins before it shows up in headline EPS.

Risk

High confidence

Downside profile looks controlled across current risk inputs.

Risk factors: liabilities/assets +61.5%, momentum +1.0%, net margin +8.6%.

Higher leverage with weak momentum and thin margins can amplify drawdown severity.

md

Pediatrix Medical Group, Inc. Market vs Earnings Trajectory

MD ยท NYSE

Loading price and EPS data...

Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. Fair Value Envelope

MD ยท NYSE

Our analysis suggests that MD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $21.84, this represents a potential HIDDEN relative to our calculated worth for Pediatrix Medical Group, Inc..

Intrinsic Value
Current Price: $21.84
3Y+142.0%
5Y-121.0%
10Y-44.0%
3Y-3.0%
5Y+10.0%
10Y-40.0%
3Y+149.0%
5Y-121.0%
10Y-49.0%
3Y+62.0%
5Y+32.0%
10Y-39.0%
3Y+84.0%
5Y+44.0%
10Y-38.0%
3Y-4.0%
5Y-33.0%
10Y-58.0%
Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. Profit Bridge

MD ยท NYSE
Revenue1.91B
Cost of Goods Sold (1.44B)
Gross Profit471.88M
Operating Expenses (240.79M)
Operating Income231.09M
Interest Expense (35.97M)
Other Income/Expense-14.65M
Pretax Income216.43M
Income Tax (51.04M)
Net Income165.39M
Net Income
165.39M

Profitability Analysis

Gross Margin

24.7%

Moderate margins typical of competitive industries. Monitor for pricing pressure or rising costs.

Operating Margin

12.1%

Acceptable margins but limited operational leverage. Operating expense control is important.

Net Profit Margin

8.6%

Moderate profitability with room for improvement. Monitor interest expenses and tax efficiency.

Effective Tax Rate

23.6%

Moderate tax rate typical for most corporations. Represents standard tax burden on profits.

Profitability Insight

Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.

24.66%
Gross Profit Margin
9%
3Y+4.0%
5Y-5.0%
10Y-24.0%
12.07%
Operating Profit Margin
-454%
3Y+38.0%
5Y+113.0%
10Y-33.0%
8.64%
Net Profit Margin
-276%
3Y+157.0%
5Y-119.0%
10Y-15.0%
19.10%
Return on Equity
-247%
3Y+157.0%
5Y-118.0%
10Y+62.0%
7.36%
Return on Assets
-260%
3Y+161.0%
5Y-131.0%
10Y+21.0%
9.67%
Return on Invested Capital
-352%
3Y+43.0%
5Y-315.0%
10Y+33.0%
MD

Pediatrix Medical Group, Inc. Cash Conversion Engine

MD ยท NYSE
Net Income0.00
Depreciation & Amortization0.00
Stock-Based Compensation0.00
Change in Working Capital41.83M
Others229.26M
Capital Expenditures-18.46M
Free Cash Flow252.63M

Cash Flow Quality Analysis

CapEx Intensity

6.8%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

+36.9%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

+$41.83M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

md

Pediatrix Medical Group, Inc. Funding & Solvency Profile

MD ยท NYSE
Cash & Cash Equivalents205.78M
Net Receivables224.80M
Inventory0.00
Other Current Assets0.00
Total Current Assets554 M
Property, Plant & Equipment1.51B
Goodwill & Intangible Assets15.94M
Long-Term Investments0.00
Other Non-Current Assets0.00
Total Non-Current Assets2 B
Total Assets
2.07B

Financial Health Analysis

Current Ratio

1.25x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Debt-to-Equity Ratio

1.36x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

111 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

27% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

md

Pediatrix Medical Group, Inc. Street Expectations Map

MD ยท NYSE

Wall Street analysts project that MD stock may experience modest gains over the coming 12 months. The consensus 1-year price target stands at 23.20, with estimates ranging from a low of 19.00 to a high of 27.00.

Lowest Target
19.00
-13.00%
Consensus Target
23.20
6.23%
Highest Target
27.00
23.63%

The consensus 1-year price target stands at 23.20, with estimates ranging from a low of 19.00 to a high of 27.00.

Analyst Consensus Analysis

Upside Potential

+6.2%

Moderate upside. Analysts expect positive returns but with limited margin of safety. Consider entry timing.

Analyst Agreement

34.5% spread

Good consensus alignment. Moderate target spread reflects general agreement on value drivers with some variance in assumptions.

Risk-Reward Profile

1.82x

Balanced risk-reward. Upside and downside potential relatively symmetric. Suitable for moderate risk tolerance with conviction in thesis.

Analyst Conviction

High

Positive outlook with reasonable agreement. Analysts generally optimistic about prospects with manageable uncertainty.

Market Sentiment Insight

Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.

md

Pediatrix Medical Group, Inc. Insider Positioning

MD ยท NYSE

During the last 12 months, insiders have sold $1.83M worth of MD shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

36.0K

855.66K

Net Activity

-856K

-$856K

3-6 Months

Bought

0

0.00

Sold

23.0K

515.43K

Net Activity

-515K

-$515K

6-9 Months

Bought

0

0.00

Sold

20.5K

457.49K

Net Activity

-457K

-$457K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

1
WSA

Weis Shirley A

Director

36.0K sharesโ€ข1 transactions

$856K

2
OMS

Ordan Mark S

Director, Officer: Chief Executive Officer

23.0K sharesโ€ข1 transactions

$515K

3
RMA

Rucker Michael A.

Director

10.5K sharesโ€ข1 transactions

$241K

4
LLA

Linynsky Laura A

Director

10.0K sharesโ€ข1 transactions

$217K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $1.83M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$856K

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

No Dividend Yield Data

MD has not reported any dividend yield values in the available annual periods.

ย 

md Dividend History

MD
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%